Developer docs
API playgroundTry for free, no card

Search company profiles

Volta Labs

Full company profile

uuid00005w6

Namestring
Volta Labs
Legal namestring
Volta Labs, Inc.
Websiteurl
voltalabs.com
Company typeenum
Private
Founded yearint
2016
Descriptiontext

Volta Labs, founded in 2016 as an MIT spinout and headquartered in Boston, Massachusetts, develops the Callisto Sample Prep System, a benchtop instrument based on proprietary electrowetting-on-dielectric (EWOD) digital fluidics. Callisto automates next-generation sequencing (NGS) sample preparation by performing DNA extraction, library preparation, and target enrichment / hybridization capture on a single walk-away platform, reducing hands-on time to under 30 minutes and eliminating manual pipetting variability. The platform is marketed as sequencer-agnostic and chemistry-agnostic: it supports short-read sequencers (Illumina, Element AVITI, MGI DNBSEQ-G50, Ultima Genomics UG 100, Roche AXELIOS 1) and long-read sequencers (PacBio, Oxford Nanopore), and integrates with reagents from Twist Bioscience, IDT, New England Biolabs, Watchmaker Genomics, QIAGEN, and other chemistry providers through pre-validated apps. Sub-branded consumables include VoltaPure (extraction), VoltaPrep (library prep), and VoltaHyb (hybridization capture).

The company primarily targets clinical and translational research laboratories, hospital-based genomics centers, sequencing service providers / core facilities, and biotech and pharma R&D operations. Documented customer deployments include UMC Utrecht (clinical WGS for prenatal and postnatal testing aligned with ISO 15189), Hartwig Medical Foundation (oncology profiling), Prinses Máxima Center for Pediatric Oncology, GeneDx (clinical genetics), Ginkgo Bioworks (synthetic biology), Norwegian Sequencing Centre at the University of Oslo, and Rush University. Volta's value proposition is structured around eliminating operator dependency, compressing hybrid capture turnaround from overnight manual protocols to same-day walk-away operation, achieving sub-2% sequencing redo rates, and maintaining >98% robustness across sample types, chemistries, and sequencing technologies.

Volta operates a direct, enterprise field-sales go-to-market with proof-of-value evaluation cycles. Revenue is generated from Callisto instrument placements plus recurring consumables (proprietary extraction, library prep, hybridization, and accessory kits) required for each app run; customers purchase partner chemistry separately from third-party reagent providers. The company has raised approximately $32M+ in disclosed venture funding, including a $20M Series A in March 2022 led by Maverick Ventures with participation from Khosla Ventures, Casdin Capital, Blindspot Ventures, and E14 Fund, followed by a 2024 round of approximately $12.7M led by Catalio Capital Management and a $20M Form D equity filing. Major strategic partnerships and compatible program memberships have been established with PacBio, Oxford Nanopore, Element, Roche, QIAGEN, Twist, IDT, NEB, and Watchmaker. The company employs between 11 and 50 people and is privately held.

Short descriptiontext

Volta Labs develops the Callisto Sample Prep System, a digital fluidics benchtop instrument automating DNA extraction, library preparation, and target enrichment for next-generation sequencing. The sequencer- and chemistry-agnostic platform serves clinical, translational, and biotech research laboratories globally.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersBoston, United States
HQ citystring
Boston
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
genomics sample preparation, NGS library prep automation, digital fluidics platform, next-generation sequencing workflows, target enrichment chemistry
Industry2 codes
PRIMARYHLAGAJAC
Scientific Data Management & Data Platforms (SDMS/Data Lakehouse for R&D)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHLAGAGAF
Analytical Development & QC Testing (Release/Stability/Potency)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Biopharma Manufacturing Services (Biologics/Cell & Gene)
NAICS code1 code
  • Analytical Laboratory Instrument Manufacturing334516
SIC code1 code
  • Laboratory Analytical Instruments3826
Product category
Genomics Automation Instruments
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model3 records
1Callisto Instrument Sales
TypeHardware Sales
Description

Sale of benchtop Callisto Sample Prep System instrument to laboratories. The instrument enables walk-away automated sample preparation and forms the hardware platform for all downstream consumables revenue.

voltalabs.com
2Consumables and Kits
TypeHardware Sales
Description

Recurring revenue from proprietary kits and reagents including extraction kits (EX0001), accessory kits (HC0001, HC0003, HC0004), and third-party chemistry reagents. Apps require Volta Labs kits alongside chemistry provider reagents (Twist, IDT, NEB, Watchmaker, etc.).

voltalabs.com
3Third-Party Reagent Partnerships
TypeLicensing Royalties
Description

Revenue from integration with partner reagent chemistries (Illumina, New England Biolabs, Twist Bioscience, KAPA/Roche, Qiagen, Watchmaker Genomics). Volta provides automated platform while customers purchase chemistry separately from partners.

voltalabs.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Supply Chain, Personnel, Marketing or Sales, Operations
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 4 records shown
1Callisto
Description

The flagship benchtop sample prep system providing walk-away automated DNA/RNA library preparation for next-generation sequencing

voltalabs.com
+3 more records
Core offering1 text field

Volta Labs develops and sells the Callisto Sample Prep System, a benchtop instrument using proprietary digital fluidics (electrowetting-on-dielectric) technology to automate next-generation sequencing (NGS) sample preparation workflows, including DNA extraction, library preparation, and hybridization capture/target enrichment. The platform is sequencer-agnostic and chemistry-agnostic, supporting multiple third-party reagent providers and major sequencing platforms (Illumina, PacBio, Oxford Nanopore, Element, MGI, Ultima Genomics). Revenue is generated through instrument sales, recurring consumables/reagent kits (VoltaPure, VoltaPrep, VoltaHyb), and validated pre-loaded apps.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 6 values shown
  • >98% robustness across sample types, chemistries, and sequencing technologies
+5 more records
Product overview1 text field

Volta Labs offers the Callisto Sample Prep System, a benchtop instrument with digital fluidics technology that provides automated, walk-away sample preparation for genomic sequencing. The system is designed as a platform-plus-apps architecture: Callisto serves as the core instrument, while plug-and-play apps (preloaded applications) provide validated workflows for specific chemistries and sequencing platforms. The product ecosystem includes VoltaPure (extraction chemistry), VoltaPrep (library prep chemistry), and VoltaHyb (hybridization capture chemistry) as supporting reagent brands. Apps available on the platform cover DNA extraction (HMW and standard), DNA library preparation (for Illumina, PacBio, Oxford Nanopore, Element, MGI, Ultima Genomics), and target enrichment via hybridization capture (IDT xGen, Twist Standard v2, Twist Fast Hyb). The platform is sequencer-agnostic and chemistry-agnostic, supporting multiple third-party reagent providers while maintaining consistent, operator-independent results.

Product and service2 records
1Callisto Sample Prep System
CategoryNGS Sample Prep Instrument
Description

Benchtop sample preparation instrument that brings push-button, walk-away automation to genomic sequencing workflows using digital fluidics technology. Automates DNA extraction, library prep, and target enrichment with up to 24 reactions per run, processing 4-24 samples per batch and supporting both short-read and long-read sequencing workflows for clinical and research laboratories.

2HMW DNA Extraction App
Scale indicator9 records

Each record includes

Type, Value, Description, Source

Partnership9 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-06-12
Description

Development partnership to integrate Twist Bioscience's hybrid capture chemistry (Fast Hybridization Kit and Standard Hybridization v2) onto the Callisto platform. Full portfolio integration completed with both Fast and Standard Hyb workflows available as fully automated apps. Combined Twist's trusted chemistry with Volta's digital fluidics automation for consistent, walk-away target enrichment.

Strategic tierStrategicTypeTechnology or IntegrationAnnounced on2026-02-26
Description

Integration of Callisto platform with Roche Sequencing's AXELIOS 1 system, announced at AGBT 2026. Expands platform compatibility and enables automated workflows for Roche's sequencing ecosystem.

Strategic tierCoreTypeTechnology or IntegrationAnnounced on2026-02-26
Description

DNA Library Preparation Application for the Oxford Nanopore Technologies Ligation Sequencing Kit V14, developed under Oxford Nanopore Compatible Products Programme. Automated workflow for PromethION platform with 120 Gb output and 99.66% SNV recall demonstrated at UMC Utrecht.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-02-23
Description

Launched Callisto Complete Kit for DNA EF (Enzymatic Fragmentation) Library Prep - fully automated PCR-free whole genome sequencing workflow combining Watchmaker's sample prep chemistry with Volta's digital fluidics automation. Joint presentation at AGBT 2026. Targets clinical and translational research laboratories.

Strategic tierStrategicTypeTechnology or IntegrationAnnounced on2025-11-14
Description

Partnership to expand NEBNext NGS library prep reagents for use with the Callisto automated platform. Integrates NEB's reagents into Callisto to support high-quality, automated whole-genome sequencing workflows across multiple sequencing platforms.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

IDT Collab Network Partner recognition. Partnership to create platform-agnostic solutions with goal of walk-away sample prep starting with target enrichment workflows and IDT xGen NGS Hyb Capture app for Callisto. IDT xGen v2 Hybridization Capture app delivers <2% redo rates with up to 20-plex multiplexing.

Strategic tierStrategicTypeTechnology or Integration
Description

Collaboration to enable walk-away sample prep and sequencing on the AVITI System. Integration to support automated workflows for Element's sequencing platform.

Strategic tierCoreTypeTechnology or Integration
Description

Formal compatible program membership. PacBio SMRTbell 3.0 DNA Library Prep app available on Callisto. HiFi long-read sequencing applications with validated workflows for PacBio platforms.

9OEM by QIAGEN
Strategic tierStrategicTypeOEM/ Whitelabel/ Licensing Partner
Description

Partnership to unlock potential of NGS sample prep through OEM integration. QIAseq FX DNA Library Prep app available on Callisto platform.

voltalabs.com
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Opentrons makes benchtop pipetting robots and workflows for NGS library prep and genomics sample preparation, directly competing with Volta Labs for walk-away, app-driven automation in translational and clinical labs.

TypeDirect peer
Description

S2 Genomics offers the Singulator, an automated tissue and nucleic acid sample preparation system for NGS, directly competing with Volta's extraction and library prep automation in clinical genomics workflows.

TypeBroad incumbent
Description

Hamilton's Microlab STAR and NGS STAR automation platforms are established workhorses for NGS library prep in clinical and research labs, representing a much larger installed base that Volta must displace.

TypeBroad incumbent
Description

Tecan's Fluent and Freedom EVO liquid handling systems are widely deployed for genomics sample preparation across clinical and pharma labs, making it one of Volta's most consequential incumbent competitors.

TypeBroad incumbent
Description

Beckman's Biomek series is a long-standing standard for automated NGS library prep, with global service and support reach that significantly exceeds Volta's footprint.

TypeBroad incumbent
Description

Revvity's Sciclone and automated NGS workstation product line competes directly with Callisto for clinical and translational genomics sample prep budgets.

TypeBroad incumbent
Description

Agilent's Bravo automated liquid handling platform and NGS prep chemistries are established competitors in genomics sample preparation, with a far larger commercial organization than Volta.

TypeEmerging player
Description

10x Genomics sells sample prep instruments (Chromium) and assays for single-cell and spatial genomics, partially overlapping Volta's sample prep automation opportunity in adjacent applications.

TypeOthers
Description

Watchmaker Genomics is a chemistry partner on Callisto (Callisto Complete Kit for DNA EF Library Prep) but also sells its own library prep reagents and may compete on chemistry-attached automation over time.

TypeBroad incumbent
Description

Illumina's DNA Prep and PCR-Free library prep chemistries run on Callisto but Illumina also sells its own automation (e.g., Illumina DNA PCR-Free Prep app) and could move further upstream into the front-end layer Volta targets.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers7 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration12 records

Each record includes

Title, Type, Description, Source

AI maturity
App detail

Has app

Feature7 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds4 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors11 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Volta Labs

Genomics Automation Instrumentsvoltalabs.com

Volta Labs develops the Callisto Sample Prep System, a digital fluidics benchtop instrument automating DNA extraction, library preparation, and target enrichment for next-generation sequencing. The sequencer- and chemistry-agnostic platform serves clinical, translational, and biotech research laboratories globally.

What Volta Labs does

Volta Labs, founded in 2016 as an MIT spinout and headquartered in Boston, Massachusetts, develops the Callisto Sample Prep System, a benchtop instrument based on proprietary electrowetting-on-dielectric (EWOD) digital fluidics. Callisto automates next-generation sequencing (NGS) sample preparation by performing DNA extraction, library preparation, and target enrichment / hybridization capture on a single walk-away platform, reducing hands-on time to under 30 minutes and eliminating manual pipetting variability. The platform is marketed as sequencer-agnostic and chemistry-agnostic: it supports short-read sequencers (Illumina, Element AVITI, MGI DNBSEQ-G50, Ultima Genomics UG 100, Roche AXELIOS 1) and long-read sequencers (PacBio, Oxford Nanopore), and integrates with reagents from Twist Bioscience, IDT, New England Biolabs, Watchmaker Genomics, QIAGEN, and other chemistry providers through pre-validated apps. Sub-branded consumables include VoltaPure (extraction), VoltaPrep (library prep), and VoltaHyb (hybridization capture).

The company primarily targets clinical and translational research laboratories, hospital-based genomics centers, sequencing service providers / core facilities, and biotech and pharma R&D operations. Documented customer deployments include UMC Utrecht (clinical WGS for prenatal and postnatal testing aligned with ISO 15189), Hartwig Medical Foundation (oncology profiling), Prinses Máxima Center for Pediatric Oncology, GeneDx (clinical genetics), Ginkgo Bioworks (synthetic biology), Norwegian Sequencing Centre at the University of Oslo, and Rush University. Volta's value proposition is structured around eliminating operator dependency, compressing hybrid capture turnaround from overnight manual protocols to same-day walk-away operation, achieving sub-2% sequencing redo rates, and maintaining >98% robustness across sample types, chemistries, and sequencing technologies.

Volta operates a direct, enterprise field-sales go-to-market with proof-of-value evaluation cycles. Revenue is generated from Callisto instrument placements plus recurring consumables (proprietary extraction, library prep, hybridization, and accessory kits) required for each app run; customers purchase partner chemistry separately from third-party reagent providers. The company has raised approximately $32M+ in disclosed venture funding, including a $20M Series A in March 2022 led by Maverick Ventures with participation from Khosla Ventures, Casdin Capital, Blindspot Ventures, and E14 Fund, followed by a 2024 round of approximately $12.7M led by Catalio Capital Management and a $20M Form D equity filing. Major strategic partnerships and compatible program memberships have been established with PacBio, Oxford Nanopore, Element, Roche, QIAGEN, Twist, IDT, NEB, and Watchmaker. The company employs between 11 and 50 people and is privately held.

Volta Labs firmographics

Firmographics
Name
Volta Labs
Legal name
Volta Labs, Inc.
Website
https://voltalabs.com
Company type
Private
Founded year
2016
Operating status
Operating
Headcount range
11–50 employees
Short description
Volta Labs develops the Callisto Sample Prep System, a digital fluidics benchtop instrument automating DNA extraction, library preparation, and target enrichment for next-generation sequencing. The sequencer- and chemistry-agnostic platform serves clinical, translational, and biotech research laboratories globally.
Ownership category
akta.pro rank

Volta Labs industry classification

Industry
Product category
Genomics Automation Instruments
NAICS
Analytical Laboratory Instrument Manufacturing (334516)
SIC
Laboratory Analytical Instruments (3826)
akta.pro industry
PRIMARYHLAGAJAC
Scientific Data Management & Data Platforms (SDMS/Data Lakehouse for R&D)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHLAGAGAF
Analytical Development & QC Testing (Release/Stability/Potency)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Biopharma Manufacturing Services (Biologics/Cell & Gene)

Keywords

  • Genomics sample preparation
  • NGS library prep automation
  • Digital fluidics platform
  • Next-generation sequencing workflows
  • Target enrichment chemistry

Where Volta Labs is headquartered

Location

Headquarters

HQ city
Boston
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Volta Labs business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Supply Chain, Personnel, Marketing or Sales, Operations

Revenue model

  1. Callisto Instrument Sales: Sale of benchtop Callisto Sample Prep System instrument to laboratories. The instrument enables walk-away automated sample preparation and forms the hardware platform for all downstream consumables revenue.
  2. Consumables and Kits: Recurring revenue from proprietary kits and reagents including extraction kits (EX0001), accessory kits (HC0001, HC0003, HC0004), and third-party chemistry reagents. Apps require Volta Labs kits alongside chemistry provider reagents (Twist, IDT, NEB, Watchmaker, etc.).
  3. Third-Party Reagent Partnerships: Revenue from integration with partner reagent chemistries (Illumina, New England Biolabs, Twist Bioscience, KAPA/Roche, Qiagen, Watchmaker Genomics). Volta provides automated platform while customers purchase chemistry separately from partners.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels6 records

Volta Labs product offering

Product offering

Core offering

Volta Labs develops and sells the Callisto Sample Prep System, a benchtop instrument using proprietary digital fluidics (electrowetting-on-dielectric) technology to automate next-generation sequencing (NGS) sample preparation workflows, including DNA extraction, library preparation, and hybridization capture/target enrichment. The platform is sequencer-agnostic and chemistry-agnostic, supporting multiple third-party reagent providers and major sequencing platforms (Illumina, PacBio, Oxford Nanopore, Element, MGI, Ultima Genomics). Revenue is generated through instrument sales, recurring consumables/reagent kits (VoltaPure, VoltaPrep, VoltaHyb), and validated pre-loaded apps.

Product overview

Volta Labs offers the Callisto Sample Prep System, a benchtop instrument with digital fluidics technology that provides automated, walk-away sample preparation for genomic sequencing. The system is designed as a platform-plus-apps architecture: Callisto serves as the core instrument, while plug-and-play apps (preloaded applications) provide validated workflows for specific chemistries and sequencing platforms. The product ecosystem includes VoltaPure (extraction chemistry), VoltaPrep (library prep chemistry), and VoltaHyb (hybridization capture chemistry) as supporting reagent brands. Apps available on the platform cover DNA extraction (HMW and standard), DNA library preparation (for Illumina, PacBio, Oxford Nanopore, Element, MGI, Ultima Genomics), and target enrichment via hybridization capture (IDT xGen, Twist Standard v2, Twist Fast Hyb). The platform is sequencer-agnostic and chemistry-agnostic, supporting multiple third-party reagent providers while maintaining consistent, operator-independent results.

Differentiator

Problem solved

Functional benefit

Brands

  • Callisto: The flagship benchtop sample prep system providing walk-away automated DNA/RNA library preparation for next-generation sequencing
  • VoltaPure
  • VoltaPrep
  • VoltaHyb

Products and services

  • Callisto Sample Prep System Benchtop sample preparation instrument that brings push-button, walk-away automation to genomic sequencing workflows using digital fluidics technology. Automates DNA extraction, library prep, and target enrichment with up to 24 reactions per run, processing 4-24 samples per batch and supporting both short-read and long-read sequencing workflows for clinical and research laboratories.
  • HMW DNA Extraction App

Quantifiable outcome

  • >98% robustness across sample types, chemistries, and sequencing technologies
  • +5 more outcomes

Companies that use Volta Labs

Customer profile

Named customers7 records

Segments3 records

Ideal customer profiles3 records

Volta Labs technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration12 records

Feature7 records

Volta Labs partnerships and signals

Strategic signal

Partnerships

Nine partnerships are on record, tiered core and strategic.

  • Twist BiosciencecoreStrategic or Co-development Partner · 12 June 2026Development partnership to integrate Twist Bioscience's hybrid capture chemistry (Fast Hybridization Kit and Standard Hybridization v2) onto the Callisto platform. Full portfolio integration completed with both Fast and Standard Hyb workflows available as fully automated apps. Combined Twist's trusted chemistry with Volta's digital fluidics automation for consistent, walk-away target enrichment.
  • Roche Sequencing (AXELIOS 1)strategicTechnology or Integration · 26 February 2026Integration of Callisto platform with Roche Sequencing's AXELIOS 1 system, announced at AGBT 2026. Expands platform compatibility and enables automated workflows for Roche's sequencing ecosystem.
  • Oxford Nanopore TechnologiescoreTechnology or Integration · 26 February 2026DNA Library Preparation Application for the Oxford Nanopore Technologies Ligation Sequencing Kit V14, developed under Oxford Nanopore Compatible Products Programme. Automated workflow for PromethION platform with 120 Gb output and 99.66% SNV recall demonstrated at UMC Utrecht.
  • Watchmaker GenomicscoreStrategic or Co-development Partner · 23 February 2026Launched Callisto Complete Kit for DNA EF (Enzymatic Fragmentation) Library Prep - fully automated PCR-free whole genome sequencing workflow combining Watchmaker's sample prep chemistry with Volta's digital fluidics automation. Joint presentation at AGBT 2026. Targets clinical and translational research laboratories.
  • New England Biolabs (NEB)strategicTechnology or Integration · 14 November 2025Partnership to expand NEBNext NGS library prep reagents for use with the Callisto automated platform. Integrates NEB's reagents into Callisto to support high-quality, automated whole-genome sequencing workflows across multiple sequencing platforms.
  • Integrated DNA Technologies (IDT)coreStrategic or Co-development PartnerIDT Collab Network Partner recognition. Partnership to create platform-agnostic solutions with goal of walk-away sample prep starting with target enrichment workflows and IDT xGen NGS Hyb Capture app for Callisto. IDT xGen v2 Hybridization Capture app delivers <2% redo rates with up to 20-plex multiplexing.
  • Element BiosciencesstrategicTechnology or IntegrationCollaboration to enable walk-away sample prep and sequencing on the AVITI System. Integration to support automated workflows for Element's sequencing platform.
  • PacBio Compatible ProgramcoreTechnology or IntegrationFormal compatible program membership. PacBio SMRTbell 3.0 DNA Library Prep app available on Callisto. HiFi long-read sequencing applications with validated workflows for PacBio platforms.
  • OEM by QIAGENstrategicOEM/ Whitelabel/ Licensing PartnerPartnership to unlock potential of NGS sample prep through OEM integration. QIAseq FX DNA Library Prep app available on Callisto platform.

Scale indicators9 records

Recent moves6 records

Expansion highlights6 records

Volta Labs competitors and assessment

Company assessment

Direct peers

  • Opentrons: Opentrons makes benchtop pipetting robots and workflows for NGS library prep and genomics sample preparation, directly competing with Volta Labs for walk-away, app-driven automation in translational and clinical labs.
  • S2 Genomics: S2 Genomics offers the Singulator, an automated tissue and nucleic acid sample preparation system for NGS, directly competing with Volta's extraction and library prep automation in clinical genomics workflows.

Broad incumbents

  • Hamilton Company: Hamilton's Microlab STAR and NGS STAR automation platforms are established workhorses for NGS library prep in clinical and research labs, representing a much larger installed base that Volta must displace.
  • Tecan: Tecan's Fluent and Freedom EVO liquid handling systems are widely deployed for genomics sample preparation across clinical and pharma labs, making it one of Volta's most consequential incumbent competitors.
  • Beckman Coulter Life Sciences (Danaher): Beckman's Biomek series is a long-standing standard for automated NGS library prep, with global service and support reach that significantly exceeds Volta's footprint.
  • Revvity (formerly PerkinElmer): Revvity's Sciclone and automated NGS workstation product line competes directly with Callisto for clinical and translational genomics sample prep budgets.
  • Agilent Technologies: Agilent's Bravo automated liquid handling platform and NGS prep chemistries are established competitors in genomics sample preparation, with a far larger commercial organization than Volta.
  • Illumina: Illumina's DNA Prep and PCR-Free library prep chemistries run on Callisto but Illumina also sells its own automation (e.g., Illumina DNA PCR-Free Prep app) and could move further upstream into the front-end layer Volta targets.

Emerging players

  • 10x Genomics: 10x Genomics sells sample prep instruments (Chromium) and assays for single-cell and spatial genomics, partially overlapping Volta's sample prep automation opportunity in adjacent applications.

Others

  • Watchmaker Genomics: Watchmaker Genomics is a chemistry partner on Callisto (Callisto Complete Kit for DNA EF Library Prep) but also sells its own library prep reagents and may compete on chemistry-attached automation over time.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

Volta Labs social profiles

Digital presence

Volta Labs financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Volta Labs leadership team

Management profile

Number of profiles

Profiles1 record

Volta Labs funding detail

Funding detail

Funding overview

Funding rounds4 records

Investors11 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Volta Labs M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Volta Labs

What does Volta Labs do?

Volta Labs develops and sells the Callisto Sample Prep System, a benchtop instrument using proprietary digital fluidics (electrowetting-on-dielectric) technology to automate next-generation sequencing (NGS) sample preparation workflows, including DNA extraction, library preparation, and hybridization capture/target enrichment. The platform is sequencer-agnostic and chemistry-agnostic, supporting multiple third-party reagent providers and major sequencing platforms (Illumina, PacBio, Oxford Nanopore, Element, MGI, Ultima Genomics). Revenue is generated through instrument sales, recurring consumables/reagent kits (VoltaPure, VoltaPrep, VoltaHyb), and validated pre-loaded apps.

Is Volta Labs a public or private company?

Volta Labs is a private company. It is classified as venture growth investor backed and is currently operating.

When was Volta Labs founded?

Volta Labs was founded in 2016. It employs 11 to 50 people.

Where is Volta Labs based?

Volta Labs is headquartered in Boston, United States, in the North America region.

How does Volta Labs make money?

Three revenue lines are on record. Callisto Instrument Sales are the primary driver. The others are consumables and Kits and third-Party Reagent Partnerships.

Who are Volta Labs's main competitors?

Direct peers on record are Opentrons and S2 Genomics. Broad incumbents are Hamilton Company, Tecan, Beckman Coulter Life Sciences (Danaher), Revvity (formerly PerkinElmer), Agilent Technologies and Illumina. 10x Genomics is listed as an emerging player. Watchmaker Genomics is listed as an others.

Does Volta Labs have an API?

No public API is recorded for Volta Labs.

What industry is Volta Labs in?

Volta Labs's product category is Genomics Automation Instruments. Its primary akta.pro industry code is HLAGAJAC, Scientific Data Management & Data Platforms (SDMS/Data Lakehouse for R&D), with a secondary code of HLAGAGAF, Analytical Development & QC Testing (Release/Stability/Potency). Its NAICS code is 334516 and its SIC code is 3826.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Business Wire BlogVolta Labs Launches AXELIOS 1 Library Prep App on Callisto™Volta Labs launched the AXELIOS 1 Library Prep App on Callisto, automating SBX-D library prep for whole-genome sequencing. The app processes 4-24 samples per run, requiring only about an hour of hands-on time, and is now in testing across Volta's global install base.PR NewswireVolta Labs intègre l'ensemble de la gamme de capture hybride de Twist à Callisto™ avec le lancement de Twist Fast HybVolta Labs announced the launch of the Twist Fast Hybridization Kit application on its Callisto Sample Prep System, making two of Twist Bioscience's hybrid capture workflows available as fully automated applications on a single platform. The automated workflow reduces target enrichment from an overnight manual process to a same-day workflow, eliminating operator variation while maintaining sequencing performance equivalent to manual preparation. The application targets labs performing comprehensive cancer profiling, whole-exome sequencing, and other targeted sequencing applications.PR NewswireVolta Labs erweitert das Twist-Hybrid-Capture-Portfolio für Callisto™ mit der Einführung von Twist Fast HybVolta Labs announced the launch of the Twist Fast Hybridization App on its Callisto Sample Prep System, developed in partnership with Twist Bioscience. The app automates hybridization-based target enrichment—one of the most complex steps in NGS sample preparation—reducing turnaround time from overnight to same-day while maintaining comparable quality control metrics and eliminating operator variability. With this launch, both Fast and Standard Hybridization v2 workflows from Twist are now available as fully automated apps on the Callisto platform, enabling labs to perform the complete spectrum of Twist Hybrid-Capture applications on a single automated system.AijournVolta Labs Brings the Complete Twist Hybrid Capture Portfolio to Callisto™ with Launch of Twist Fast HybVolta Labs announced the launch of the Twist Fast Hyb App for Twist Bioscience's Fast Hybridization Kit on the Callisto Sample Prep System, completing the full Twist hybrid capture portfolio on the platform. The automated workflow reduces turnaround from overnight to same-day sample-to-sequencer processing while maintaining equivalent sequencing performance to manual preparation. This expansion enables labs to run both Fast and Standard Hybridization protocols on a single automated platform, eliminating operator-to-operator variability through fully walk-away automation.PR NewswireVolta Labs Brings the Complete Twist Hybrid Capture Portfolio to Callisto™ with Launch of Twist Fast HybVolta Labs announced the launch of the Twist Fast Hyb App on the Callisto Sample Prep System, enabling full automation of Twist Bioscience's Fast Hybridization protocol for next-generation sequencing sample preparation. The automated workflow reduces hybridization from an overnight process to a same-day, walk-away operation while maintaining run-to-run consistency and eliminating operator-to-operator variability. Both the Fast and Standard Hybridization v2 Apps are now available on Callisto, providing labs with a complete automated platform for Twist's hybrid capture portfolio.PR NewswireVolta Labs Brings the Complete Twist Hybrid Capture Portfolio to Callisto™ with Launch of Twist Fast HybVolta Labs announced the launch of the Twist Fast Hyb App on the Callisto Sample Prep System, developed in collaboration with Twist Bioscience, which automates hybridization-based target enrichment workflows for next-generation sequencing. The app reduces turnaround time from overnight to same-day while maintaining equivalent sequencing performance to manual preparation and eliminating operator-to-operator variability. Both Twist Bioscience's Fast Hybridization and Standard Hybridization v2 workflows are now available as automated apps on Callisto, providing labs with a fully walk-away target enrichment solution.Clinical Lab ProductsVolta Labs Launches Automated Library Prep for Oxford Nanopore Sequencing KitsVolta Labs announced the availability of its DNA Library Preparation Application for the Oxford Nanopore Technologies Ligation Sequencing Kit V14, developed under the Oxford Nanopore Compatible Products Programme. In benchmarking studies and an independent clinical evaluation at University Medical Center Utrecht, Callisto-prepared libraries reached up to 120 gigabases of output on a single PromethION flow cell with 99.66% single nucleotide variant recall, supporting routine whole genome sequencing workflows aligned to ISO 15189 standards.PR NewswireVolta Labs lanza una solución automatizada para la preparación de bibliotecasVolta Labs announced its Callisto library prep app for Oxford Nanopore's V14 sequencing kit, enabling fully automated library prep. Independent testing at UMC Utrecht showed up to 120 Gb output per PromethION flow cell with 99.66% SNV recovery. The company aims to support ISO 15189 accreditation for clinical whole-genome sequencing.PR NewswireVolta Labs launches automated library preparation solution for the Oxford Nanopore Ligation Sequencing Kit V14Volta Labs announced the launch of its automated DNA library preparation solution, Callisto™, for Oxford Nanopore Technologies' Ligation Sequencing Kit V14. The product enables fully automated, high-throughput whole genome sequencing with improved accuracy and efficiency, as demonstrated in clinical evaluations at UMC Utrecht.PR NewswireVolta Labs launches automated library preparation solution for the Oxford Nanopore Ligation Sequencing Kit V14Volta Labs announced the launch of its automated DNA library preparation solution, Callisto™, for Oxford Nanopore's Sequencing Kit V14, which is optimized for the PromethION platform. The solution has demonstrated high output and diagnostic accuracy in independent clinical evaluations at University Medical Center Utrecht, supporting routine whole genome sequencing aligned with ISO standards.